Platelet Disorders

39
Platelet Disorders

description

Platelet Disorders. Platelets. * Disc shape cells 2-4 mm in diameter. *They have blue grey cytoplasm with red lysosomal granules, but devoid of nuclei. *They are formed in BM from their progenitors the megakaryocytes . - PowerPoint PPT Presentation

Transcript of Platelet Disorders

Page 1: Platelet Disorders

Platelet Disorders

Page 2: Platelet Disorders

Platelets

*Disc shape cells 2-4 mm in diameter .

*They have blue grey cytoplasm with red lysosomal granules, but devoid of nuclei.

*They are formed in BM from their progenitors the megakaryocytes .

*Megakaryocytes are giant cells with multilobed nuclei (4-6) that produce platelets from their cytoplasm by the process of

budding.

Page 3: Platelet Disorders

*A hematopoietic growth factor for megakaryocytes is thrombopoietin

*IL-11 also stimulates platelet production. *Each megakaryocyte produces 1000-3000

platelets .*Their normal count in peripheral blood is

150000-300000/µL.*One third resides in splenic pool & two thirds

in circulation.*Their life span is 9-10 days.

Page 4: Platelet Disorders

Platelet function

They contain 3 types of secretory granules: *lysosomes, *α-granules,

*dense bodies.

Page 5: Platelet Disorders

α- granules

contain *platelet-specific proteins (PF4, β-thromboglobulin) & *several growth factors including PDGF

& TGF-β .

*They also contain several hemostatic proteins including fibrinogen, FV, vWF

synthesized by megakaryocytes.

Page 6: Platelet Disorders

Dense bodies (δ-granules)

contain *ATP, *ADP, *Ca+2,

*Serotonin

Page 7: Platelet Disorders

*Adhesion to blood vessel wall ,*Aggregation to form the primary hemostatic plug at

site of blood vessel injury& , *Release of vasoconstrictor substances from

intracellular granules in response to variety of substances are the main functions of platelets. Platelets also provide surface for activation of coagulation factors. Activated platelets expose specific receptors that bind to F Xa & F Va increasing their local concentration thus accelerating prothrombin activation. F X is activated

by F IXa & F VIII on platelet surface.

Page 8: Platelet Disorders

They contain a membrane - phospholipase C that can be stimulated by activating agents to hydrolyze endogenous phosphatidyl

inositol to form a diglyceride .

This is converted to arachidonic acid by diglyceride lipase enzyme .

Arachidonic acid will be converted to prostaglandins (PG G2 & thromboxane A2)

under the influence of cyclo-oxygenase.

Page 9: Platelet Disorders

Platelet function tests

1 .Bleeding time --- It is prolonged in thrombocytopenia, functional platelet

abnormalities & vW disease .2 .Platelet aggregometry --- Response of

platelets to variety of aggregating agents (ADP, fibrinogen, Collagen, ristocetin & adrenaline) is quantitated. It is useful in diagnosing hereditary platelet disorders.

Page 10: Platelet Disorders

Thrombocytopenia

It is a condition in which platelet count is below normal level.

Page 11: Platelet Disorders

Causes 1 -Aplastic anemia .

2 -Leukemia .3 -Tumors metastatic to BM.

4 -Myelofibrosis.5 -Megaloblastic anemia.

6 -Peripheral platelet destruction a- Immune

ITP, SLE, PAN, CLL, NHL, infectious mono, CMV infection, HIV, quinine, quinidine, heparin & sulfa .

b- Non-immune DIC, TTP, PNH, acute transplant rejection .

7 -Disorders of distribution--- Hypersplenism .8 -Dilutional --- Old banked blood transfusion.

Page 12: Platelet Disorders

Idiopathic Thrombocytopenic Purpura: (ITP)

It is a bleeding disorder caused by autoimmune Abs destroying patient's own platelets by phagocytosis in the spleen by

Mφ (to a lesser degree in the liver).

Page 13: Platelet Disorders

Epidemiology *Children are affected by an acute type of

illness following URT infection (usually viral) .

♀ = ♂*incidence .

*Adults are affected by a more gradual onset of disease with chronic course & without

preceding illness .

*Age < 40 years

= ♂ :♀*3-4:1

Page 14: Platelet Disorders

S & S Skin shows petechiae (pinpoint red

hemorrhagic spots) & ecchymoses.

Mucosal bleeding --- bleeding gum, epistaxis, menorrhagia, metrorrhagia, GI bleeding & hematuria

Intracranial hemorrhage is seen in 1%. Risk of death 5%

No splenomegaly.

Page 15: Platelet Disorders

Dx Platelet count < normal (Thrombocytopenia)

* If > 100000/µL no spontaneous bleeding even with major surgery

* If 50000-100000/µL Bleeding more than normal with severe trauma

* If 20000-50000/µL Bleeding occurs with minor trauma

* If < 20000/µL spontaneous bleeding occurs

* If < 10000/µL patients are at high risk of severe bleeding

Page 16: Platelet Disorders

Blood film shows scanty platelets

BM examination is normal with abundant megakaryocytes

Serum antiplatelet Abs --- anti-Gp IIb-IIIa

Platelet surface attached Abs assay (IgG 90%) – more complex & its significance is not clear

Page 17: Platelet Disorders

DDx SLE ,

PAN ,

CLL ,

NHL ,

EBV & CMV mononucleosis,

HIV

Page 18: Platelet Disorders

℞ Children have a self-limited disease & 70%

recover in 4-6 weeks .

Asymptomatic adult pts with platelet count > 40000/µL are observed periodically & need no ttt

Page 19: Platelet Disorders

Prednisolone is the 1st line of ttt 1-2 mg/kg body wt daily

* inhibits Mφ ingestion of Ab-coated platelets

* suppresses Ab synthesis

* have stabilizing effect on blood vessels wall .

-- 80-90% of pts will have rise of platelet count to hemostatic level within 2-3 weeks

-- Tapered slowly after achieving normal count

Page 20: Platelet Disorders

Splenectomy *improves the count in 70% pts & sustained

remission in 60%

*Up to 2 weeks later

*For pts not responding to steroids

*No test can predict which pts can detect which pts respond to it

Page 21: Platelet Disorders

Intravenous Immunoglobulin (IVIG) *Effective in pts with active bleeding &

before major surgery

* Rise platelet count in 3-5 days (The most rapid agent)

* Blocks receptors to Abs on Mφ therefore inhibiting phagocytosis

* High dose needed 1g/kg B wt/day on 2 successive days

* Very expensive

* Its effect is unfortunately transient

Page 22: Platelet Disorders

Anti-Rh antibody (RhoGAM)

*Less expensive alternative to IVIG

* Mechanism is the same i.e. reticuloendothelial cells blockade

Page 23: Platelet Disorders

Danazol (Danol)

*200mg three times per day

* Induces remission in 40% of cases

* Response is delayed 4-6 weeks

* Impeded androgen

* Mechanism of action remains unknown

Page 24: Platelet Disorders

Vincristine (Oncovin) & Vinblastine (Velbe)

*Cytotoxic drugs

*Given IV

*Raise platelet within 1-2 weeks

*Transient & nonsustained response

Page 25: Platelet Disorders

Immunosuppressants

Cyclophosphamide & Azathioprine

* Improve platelet count in 20-30% of cases

* Risk of toxicity has to be weighed against potential benefit

Page 26: Platelet Disorders

Refractory cases

–Combination chemotherapy

--Pulsed high dose dexamethasone

Page 27: Platelet Disorders

ITP in Pregnancy

*Complicated by additional risk to the fetus (thrombocytopenia due to maternal Abs) , newborn intraventricular hemorrhage & GI bleeding

*C/S delivery is recommended to decrease risk of intracranial bleeding in

the newborn.

Page 28: Platelet Disorders

Henoch-Schonlein Purpura

Also called anaphylactoid purpura

Symmetrical palpable purpura is seen on the extensor surfaces of the limbs &

buttocks (maculopapular rash) .

It is usually seen in children (rare in adults)

Page 29: Platelet Disorders

Patients may give a history of a recent infection

Manifestations in addition to palpable purpura include arthralgias, abdominal pain& melena

Complications include glomerulonephritis, hypertension & intussusception

No splenomegaly

Platelet count is normal

Page 30: Platelet Disorders

Histopathologic examination shows small blood vessel leucocytoclastic vasculitis with IgA & complement deposition

It is self limited over 1-2 months

Symptomatic response is seen with Prednisolone & analgesics

Relapses may complicate the course of the disease

Bad prognostic factors – Adult age, renal involvement & recurrent relapsing type

Page 31: Platelet Disorders

Functional platelet disorders Hereditary

•Glanzmann's thrombasthenia

•Bernard-Soulier syndrome

•Storage pool disease

Page 32: Platelet Disorders

Glanzmann's thrombasthenia

•AR inheritance

• Prolonged bleeding time

• Platelets fail to aggregate with ADP, adrenaline, collagen, or thrombin

• Deficiency of platelet membrane GP IIb-IIIa (two glycoproteins that normally serve as the receptor for fibrinogen in activated platelets)

Page 33: Platelet Disorders

Bernard-Soulier syndrome

•AR inheritance

• Deficiency of platelet membrane GPIb-IX causing defective binding of vWF

• Peripheral blood smear – Giant platelets

• Platelet aggregate normally with ADP, collagen, or adrenaline, but fail to respond to ristocetin

Page 34: Platelet Disorders

Storage pool disease

•AD inheritance •Platelet storage granules are decreased in

no. & content •Abnormal granules formation in

megakaryocytes •Mild bleeding mainly in women

•Decreased platelet aggregation because of inadequate secretion of ADP

•Sometimes associated with oculocutaneous albinism,

Page 35: Platelet Disorders
Page 36: Platelet Disorders
Page 37: Platelet Disorders
Page 38: Platelet Disorders

ITP

Page 39: Platelet Disorders

MEGAK